By Professor Alexander Swarbrick

Journal articles

Swarbrick A; Junankar SR; Batten M, 2013, 'Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy', OncoImmunology, 2, http://dx.doi.org/10.4161/onci.25409

Nair R; Roden DL; Teo WS; McFarland A; Junankar S; Ye S; Nguyen A; Yang J; Nikolic I; Hui M; Morey A; Shah J; Pfefferle AD; Usary J; Selinger C; Baker LA; Armstrong N; Cowley MJ; Naylor MJ; Ormandy CJ; Lakhani SR; Herschkowitz JI; Perou CM; Kaplan W; O'Toole SA; Swarbrick A, 2013, 'c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer', Oncogene, http://dx.doi.org/10.1038/onc.2013.368

Koese M; Rentero C; Kota BP; Hoque M; Cairns R; Wood P; Vilà De Muga S; Reverter M; Alvarez-Guaita A; Monastyrskaya K; Hughes WE; Swarbrick A; Tebar F; Daly RJ; Enrich C; Grewal T, 2013, 'Annexin A6 is a scaffold for PKCα to promote EGFR inactivation', Oncogene, 32, pp. 2858 - 2872, http://dx.doi.org/10.1038/onc.2012.303

Al-Ejeh F; Shi W; Miranda M; Simpson PT; Vargas AC; Song S; Wiegmans AP; Swarbrick A; Welm AL; Brown MP; Chenevix-Trench G; Lakhani SR; Khanna KK, 2013, 'Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor', Journal of Nuclear Medicine, 54, pp. 913 - 921, http://dx.doi.org/10.2967/jnumed.112.111534

Warrier S; Sellinger C; Beith JM; Cazet A; Swarbrick A; Carmalt H; O'Toole S, 2013, 'Claudin-1 as a novel transcriptional target of hedgehog signaling and a predictor for outcome in breast cancer.', Journal of Clinical Oncology, 31, pp. 1053 - 1053, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1053

Hui M; Cazet A; Nair R; Watkins DN; O'Toole SA; Swarbrick A, 2013, 'The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy', Breast Cancer Research, 15, http://dx.doi.org/10.1186/bcr3401

Croucher DR; Hochgräfe F; Zhang L; Liu L; Lyons RJ; Rickwood D; Tactacan CM; Browne BC; Ali N; Chan H; Shearer R; Gallego-Ortega D; Saunders DN; Swarbrick A; Daly RJ, 2013, 'Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway', Cancer Research, 73, pp. 1969 - 1980, http://dx.doi.org/10.1158/0008-5472.CAN-12-1472

Plummer PN; Freeman R; Taft RJ; Vider J; Sax M; Umer BA; Gao D; Johns C; Mattick JS; Wilton SD; Ferro V; McMillan NAJ; Swarbrick A; Mittal V; Mellick AS, 2013, 'MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells', Cancer Research, 73, pp. 341 - 352, http://dx.doi.org/10.1158/0008-5472.CAN-12-0271

Lee P; Ho KKY; Swarbrick A, 2013, 'Brown Adipose Tissue in Adult Humans: A Metabolic Renaissance', Endocrine Reviews, 34, pp. 413 - 438, http://dx.doi.org/10.1210/er.2012-1081

Natividad KDT; Junankar S; Mohd redzwan N; Wirasinha RC; King C; Brink R; Swarbrick A; Batten ML; Nair R, 2013, 'Interleukin-27 Signaling Promotes Immunity against Endogenously Arising Murine Tumors', PLoS ONE, 8, pp. e57469, http://dx.doi.org/10.1371/journal.pone.0057469

O'Toole S; Beith JM; Millar EKA; West R; McLean A; Cazet A; Swarbrick A; Oakes , 2013, 'Therapeutic targets in triple negative breast cancer', Journal of Clinical Pathology, 66, pp. 530 - 542, http://dx.doi.org/10.1136/jclinpath-2012-201361

McFarland A; Phua Y; Swarbrick A; Nair R, 2012, 'Meeting The 3Rs with the Use of In Vivo Imaging', JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 51, pp. 687 - 688, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000313303300243&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O’Toole S; Machakel D; Millar E; Nair R; Cooper C; Qiu MR; McLeod D; Sutherland R; Watkins N; Swarbrick A, 2012, '35. Hedgehog overexpression is regulated by stromal interactions and predicts for poor outcome in invasive ductal carcinoma', Pathology, 44, pp. S114 - S114, http://dx.doi.org/10.1016/s0031-3025(16)32927-0

Kalyuga M; Gallego-Ortega D; Lee H; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Rosalind launchbury R; Statham A; Armstrong NJ; Alles MC; Adelaide young A; Egger A; Au W; Piggin CL; Evans C; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JMW; Robert i nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ, 2012, 'ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer', PLoS Biology, 10, pp. e1001461, http://dx.doi.org/10.1371/journal.pbio.1001461

Swarbrick A; Daly RJ, 2012, 'New insights into signalling networks regulating breast cancer stem cells', Breast Cancer Research, 14, pp. 321, http://dx.doi.org/10.1186/bcr3209

O Toole S; Swarbrick A; Sutherland RL, 2009, 'The Hedgehog signalling pathway as a therapeutic target in early breast cancer development', Expert Opinion on Therapeutic Targets, 13, pp. 1095 - 1103

Swarbrick A, 2008, 'Review of: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer', Breast Cancer Online, 11, http://dx.doi.org/10.1017/S1470903108006688

Butt A; Caldon CE; Mcneil CM; Swarbrick A; Musgrove EA; Sutherland RL, 2008, 'Cell cycle machinery: Links with genesis and treatment of breast cancer', Advances in Experimental Medicine and Biology, 630, pp. 189 - 205

Caldon CE; Swarbrick A; Lee CS; Sutherland RL; Musgrove EA, 2008, 'The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini', Cancer research, 68, pp. 3026 - 3036, http://dx.doi.org/10.1158/0008-5472.CAN-07-3079

Kairouz R; Parmar J; Lyons RJ; Swarbrick A; Musgrove EA; Daly RJ, 2005, 'Hormonal regulation of the grb14 signal modulator and its role in cellcycle progression of MCF-7 human breast cancer cells', Journal of Cellular Physiology, 203, pp. 85 - 93

Swarbrick A; Akerfeldt M; Lee CS; Sergio CM; Caldon CE; Hunter LJ; Sutherland RL; Musgrove EA; Lee CS, 2005, 'Regulation of cyclin expression and cell cycle progression in breastepithelial cells by the helix-loop-helix protein Id1', Oncogene, 24, pp. 381 - 389

Carroll JS; Lynch DK; Swarbrick A; Renoir JM; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL, 2003, 'p27^Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells', Cancer Research, 63, pp. 4322 - 4326

Sutherland RL; Carroll JS; Sergio CM; Swarbrick A; Musgrove EA, 2003, '97. Steroid regulation of breast cancer cell proliferation', Reproduction, Fertility and Development, 15, pp. 97 - 97, http://dx.doi.org/10.1071/srb03ab97

Carroll JS; Lynch DK; Swarbrick A; Renoir J; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL, 2003, 'p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells', Cancer research, 63, pp. 4322 - 4326

Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL, 2002, 'Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: Implications for the antiproliferative effects of antiestrogens', Cancer Research, 62, pp. 3126 - 3131

Wei M; Cohen SM; Silverman AP; Lippard SJ, 2001, 'Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.', J Biol Chem, 276, pp. 38774 - 38780, http://dx.doi.org/10.1074/jbc.M106374200

Swarbrick A; Lee CSL; Sutherland RL; Musgrove EA, 2000, 'Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells', Molecular and Cellular Biology, 20, pp. 2581 - 2591, http://dx.doi.org/10.1128/MCB.20.7.2581-2591.2000

Swarbrick A; Murby EJ; Hume P, 1997, 'Post-column electrochemical oxidation of leuco malachite green for the analysis of rainbow trout flesh using HPLC with absorbance detection', Journal of Liquid Chromatography and Related Technologies, 20, pp. 2269 - 2280, http://dx.doi.org/10.1080/10826079708006562

Swarbrick A; Lim RL; Upcroft JA; Stewart TS, 1997, 'Nucleotide variation in the cytidine triphosphate synthetase gene of Giardia duodenalis', Journal of Eukaryotic Microbiology, pp. 531 - 534

Back to profile page